Home » Topics » Regulatory

Regulatory
RSS

E.U. approval for Somavert

Nov. 21, 2002

FDA approves SuperGen's NDA to market Mitozytrex

Nov. 20, 2002

First approval for new antipsychotic drug granted by FDA

Nov. 19, 2002

Label change for Biogen's Avonex approved

Nov. 18, 2002

First approval obtained for Cialis

Nov. 15, 2002

Health Canada approves irbesartan for diabetic renal disease

Nov. 13, 2002

Pfizer announces approval of Lipitor for use in children

Nov. 13, 2002

Crestor receives first approval in Europe

Nov. 11, 2002

Myfortic receives first major approval in Switzerland

Nov. 8, 2002

FDA approves new indication for SecreFlo

Nov. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...